-

Prognos Health Enhances HCP Precision Marketing Suite with Planning Engine to Accelerate RWD Insights and Improve Health Outcomes

Pharma marketers now have easy access to identify patient populations with precision and plan before they acquire the right RWD to integrate into their HCP omnichannel disease awareness campaigns.

NEW YORK--(BUSINESS WIRE)--Real world data marketplace and analytics platform leader, Prognos Health, today announced the launch of their real world data planning engine to help pharmaceutical commercial teams and their partners to quickly design sophisticated HCP segmentation aligned to key patient health events to drive better outcomes.

Prognos currently serves more than 50 pharmaceutical brands with their HCP precision marketing suite to effectively plan, activate and optimize promotional strategies across all digital and offline channels. The new planning tool will give pharma brands all the insights they require before acquiring and activating real world data into their omnichannel stacks.

“Life science commercial teams are challenged with quickly harnessing data to enrich their segmentation strategies,” says Matt Apprendi, VP Marketing & Media Solutions at Prognos Health. “The planning engine enables commercial teams to glean insights derived from RWD faster to power sophisticated HCP segmentation strategies aligned to key patient events.”

The new planning tool is fully integrated within Prognos Marketplace and is available for any pharmaceutical company ready to find insights quicker to activate branded and nonbranded disease awareness tactics.

About Prognos Health

Prognos® Health is accelerating real world data access and insights to improve health outcomes through the Prognos Marketplace — the largest collection of integrated medical records on 325 million de-identified U.S. patients. The Marketplace is built on Prognos Factor®, a specialized healthcare analytics platform that leverages a patent-pending database management system enabling no-code exploration of hundreds of billions of medical records at interactive speeds. The Marketplace allows healthcare clients to assess the value of data before purchase and license only the data needed. Embedded standardization and linkability makes the data analytics-ready, accelerating speed to value. Use cases include targeting specific patient/provider populations, commercial and HEOR process optimization, clinical research studies, and medical underwriting risk assessment. For more information visit prognoshealth.com

Contacts

Matt Apprendi
pr@prognoshealth.com

Prognos Health

Details
Headquarters: New York, NY
CEO: Sundeep Bhan
Employees: 125
Organization: PRI

Release Versions

Contacts

Matt Apprendi
pr@prognoshealth.com

More News From Prognos Health

Dr. Steven Zatz Joins Prognos® Health Board of Directors

NEW YORK--(BUSINESS WIRE)--Former WebMD CEO, Dr. Steven Zatz, joins Prognos Health Board of Directors, bringing a wealth of industry insight to help drive direction and vision....

Prognos Health Named to NYC Digital Health 100 by NYCHBL

NEW YORK--(BUSINESS WIRE)--Prognos Health, a leader in accelerating RWD access and insights through its RWD marketplace and platform, was named to the Digital Health 100....

Survey, Whitepaper from PrognosⓇ Health and Reuters Events™ Uncovers RWD Trends in the Pharmaceutical Industry

NEW YORK--(BUSINESS WIRE)--Prognos Health recently partnered with ReutersEvents to survey brand, commercial strategy, and data science leaders in the pharmaceutical industry to understand current challenges, priorities, and opportunities when it comes to leveraging real-world data (RWD) for drug therapy commercialization. The results are published in a new whitepaper titled Real World Data in Life Sciences: Faster Launch, Increased Adoption, Higher Revenue, and a Playbook for Commercial Success...
Back to Newsroom